Rechercher | Webyourself Social Media Platform

Ashwini Bakhade Ajout d’un nouvel article Autre
2023-11-07 10:57:49 -

Memantine market driven by demand for Alzheimer's disease drugs connected with market driver outline as a part of heading
The global Memantine Market is estimated to be valued at US$ 565.93 Bn in 2022 and is expected to exhibit a CAGR of 3.87% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Memantine is a prescription drug used for the treatment of moderate to severe Alzheimer's disease. It belongs to a class of drugs called NMDA receptor...

0 Commentaires 0 Parts 1366 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Ashwini Bakhade Ajout d’un nouvel article Health
2024-09-09 11:13:14 -

Memantine Market Poised for Growth Due to Advancements in Alzheimer's Disease Treatment
Memantine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist primarily used for treating moderate to severe Alzheimer's disease. It functions by regulating glutamate activity and providing neuroprotection against toxicity. Memantine is approved as a treatment option either as a monotherapy or in combination with cholinesterase inhibitors for patients suffering from moderate to...

0 Commentaires 0 Parts 274 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Ashwini Bakhade Ajout d’un nouvel article Autre
2024-06-04 10:58:50 -

The Global Memantine Market Growth Is driven by rising prevalence of Alzheimer's disease
The memantine market overview involves neuroprotective properties of memantine for treatment of moderate to severe forms of Alzheimer's disease. Memantine is an NMDA receptor antagonist approved as an add-on therapy to cholinesterase inhibitors for patients with moderate to severe Alzheimer's disease. It regulates glutamate activity to inhibit neurotoxicity and protect neurons from...

0 Commentaires 0 Parts 688 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Nilam Cmi Ajout d’un nouvel article Health
2024-11-05 10:57:46 -

The Rising Demand for Alzheimer's Drugs Drives the Memantine Market
Memantine is an orally administered drug used for the treatment of Alzheimer's disease symptoms. It works as an NMDA receptor antagonist. The drug helps improve cognitive functions, memory, thinking skills and ability to perform daily routine activities in patients with moderate to severe Alzheimer's disease. It reduces the effect of glutamate which can damage or kill nerve cells. The Global...

0 Commentaires 0 Parts 49 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Leena Leena Ajout d’un nouvel article Autre
2024-02-13 11:55:39 -

Understanding Memantine: Mechanism of Action, Clinical Efficacy, Dosage, and Safety in Alzheimer's Disease Treatment
Clinical StudiesSeveral large clinical trials have evaluated the effectiveness and safety profile of memantine in the treatment of moderate to severe Alzheimer's disease. Some of the key studies are:- The MEM-MD-02 Study: This 24-week study compared memantine 20 mg/day to placebo in nursing home residents with severe Alzheimer's disease. Results showed memantine significantly improved...

0 Commentaires 0 Parts 978 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Nilesh Tak Ajout d’un nouvel article Autre
2024-04-29 19:15:40 -

Analyzing theMemantine Market: Drivers, Opportunities, and Trends
This Memantine market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market...

0 Commentaires 0 Parts 764 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!